ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
도네페질 시장 규모는 최근 꾸준히 확대하고 있습니다. 2025년 10억 4,000만 달러에서 2026년에는 10억 9,000만 달러로, CAGR 4.5%로 성장할 것으로 예상됩니다. 지난 수년간의 성장은 전 세계 고령화, 알츠하이머병 유병률 증가, 콜린에스테라아제 억제제의 보급 확대, 치매 진단율 향상, 신경과 치료 시설 확충 등이 요인으로 꼽힙니다.
도네페질 시장 규모는 향후 몇 년간 꾸준한 성장이 전망됩니다. 2030년에는 13억 달러에 달하고, CAGR은 4.5%가 될 전망입니다. 예측 기간 동안의 성장 요인으로는 전 세계 노인 인구 증가, 조기 치매 치료에 대한 인식 개선, 비용 효율적인 제네릭 의약품에 대한 수요 확대, 재택 인지 치료 확대, 신경 퇴행성 질환에 대한 의료비 지출 증가 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 알츠하이머병 관리에서 장기 사용 증가, 경구용 인지기능 개선 요법의 선호도 증가, 제네릭 도네페질 제제의 수요 확대, 경증 및 중등도 알츠하이머 환자 치료 확대, 노인 신경학 치료에 대한 관심 증가 등을 들 수 있습니다.
알츠하이머병의 유병률 증가는 향후 몇 년 동안 도네페질 시장의 성장을 견인할 것으로 예상됩니다. 알츠하이머병은 진행성 신경질환으로 뇌세포의 퇴화 및 사멸을 일으켜 기억상실, 인지기능 장애, 행동변화를 가져오는 질환입니다. 고령화, 총인구 증가, 생활습관의 영향, 만성질환의 증가, 유전적 소인, 환경적 노출 등의 요인으로 알츠하이머병 환자 수는 증가 추세에 있습니다. 도네페질은 뇌 내 아세틸콜린 수치에 작용하여 인지기능과 일상생활 능력을 향상시켜 알츠하이머병에 대한 효과적인 대증요법을 제공합니다. 예를 들어, 2024년 5월 미국 알츠하이머 협회(알츠하이머병 치료, 지원, 연구에 주력하는 비영리 단체)가 발표한 보고서에 따르면, 알츠하이머병 진단을 받은 65세 이상 미국인의 수는 2022년 650만 명에서 2024년 약 690만 명으로 증가할 것으로 예상됩니다. 그 결과, 알츠하이머병의 증가 추세는 도네페질 시장 확대를 견인하고 있습니다.
도네페질 분야의 주요 기업들은 환자의 복약 순응도를 높이고 알츠하이머병 환자의 치료 관련 불편함을 최소화하기 위해 주 1회 투여형, 서방형 경피흡수 시스템 등 혁신적인 투약 기술 개발에 주력하고 있습니다. 도네페질 경피 흡수 시스템은 피부를 통해 약물을 제어된 속도로 투여하기 때문에 초기 통과 효과를 피하고 경구 투여에 일반적으로 수반되는 위장 장애의 위험을 줄입니다. 예를 들어, 2024년 3월 미국 바이오 제약사 코리움(Corium, Inc.)은 차세대 제제 'Adlarity'를 발표했습니다. 본 제제는 패치 접착력 향상, 피부 내약성 개선, 7일간 지속 방출 프로파일의 안정화를 통해 치료 효과의 단절을 방지합니다. 이 개선 시스템은 경구약의 일상적인 복용이 어려운 노인들의 복약 부담 경감과 복약 순응도를 높이고, 알츠하이머병 케어의 간소화를 목적으로 코리움사가 개발했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Donepezil is a medication used to manage symptoms of Alzheimer's disease by preventing the breakdown of acetylcholine, a neurotransmitter essential for memory and cognitive function. It acts as a cholinesterase inhibitor, enhancing cognitive abilities and slowing the advancement of symptoms in individuals with mild to moderate Alzheimer's disease.
The primary dosages of donepezil are 5 mg, 10 mg, and 23 mg. Donepezil 5 mg represents a particular strength of the drug donepezil hydrochloride, which is mainly prescribed for managing dementia linked to Alzheimer's disease. It is administered through various routes, including oral and transdermal methods, and is utilized in different settings such as hospitals, clinics, and pharmacies.
Tariffs have influenced the donepezil market by raising the cost of imported active pharmaceutical ingredients and finished generic formulations used in Alzheimer's disease treatment. These impacts are most visible in tablet manufacturing and retail pharmacy distribution, where pricing sensitivity is high. Regions such as North America and Asia Pacific have experienced higher input costs due to reliance on cross border pharmaceutical sourcing. Rising tariff related expenses have influenced generic drug pricing, procurement planning, and inventory strategies. At the same time, tariffs have encouraged domestic generic drug manufacturing, expanded local production capacity, and strengthened regional pharmaceutical supply chains over the long term.
The donepezil market research report is one of a series of new reports from The Business Research Company that provides donepezil market statistics, including donepezil industry global market size, regional shares, competitors with a donepezil market share, detailed donepezil market segments, market trends and opportunities, and any further data you may need to thrive in the donepezil industry. This donepezil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The donepezil market size has grown steadily in recent years. It will grow from $1.04 billion in 2025 to $1.09 billion in 2026 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to aging global population, rising prevalence of alzheimer's disease, widespread adoption of cholinesterase inhibitors, improved dementia diagnosis rates, expansion of neurology treatment facilities.
The donepezil market size is expected to see steady growth in the next few years. It will grow to $1.3 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to growth in elderly population worldwide, increasing awareness of early dementia treatment, rising demand for cost-effective generics, expansion of home-based cognitive care, increasing healthcare expenditure on neurodegenerative diseases. Major trends in the forecast period include rising long-term use in alzheimer's disease management, increasing preference for oral cognitive enhancement therapies, growing demand for generic donepezil formulations, expansion of treatment in mild to moderate alzheimer's cases, increased focus on geriatric neurology care.
The rising prevalence of Alzheimer's disease is anticipated to drive the growth of the donepezil market in the coming years. Alzheimer's disease is a progressive neurological disorder that leads to the degeneration and death of brain cells, resulting in memory loss, cognitive impairment, and behavioral changes. The number of Alzheimer's cases is increasing due to factors such as an aging population, overall population growth, lifestyle-related influences, a rise in chronic conditions, genetic predispositions, and environmental exposures. Donepezil provides an effective symptomatic treatment for Alzheimer's disease by improving cognitive function and daily living abilities through its effect on acetylcholine levels in the brain. For example, in May 2024, a report by the Alzheimer's Association, a US-based nonprofit organization focused on Alzheimer's care, support, and research, indicated that the number of Americans aged 65 and older diagnosed with Alzheimer's dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the growing incidence of Alzheimer's is fueling the expansion of the donepezil market.
Major companies in the donepezil sector are concentrating on developing innovative delivery technologies, including once-weekly and extended-release transdermal systems, to enhance patient adherence and minimize treatment-related discomfort in individuals with Alzheimer's. A donepezil transdermal system administers the medication through the skin at a controlled pace, bypassing first-pass metabolism and reducing the likelihood of gastrointestinal side effects commonly associated with oral administration. For example, in March 2024, Corium, Inc., a US-based biopharmaceutical firm, launched its next-generation Adlarity formulation featuring improved patch adhesion, better skin tolerability, and a more consistent 7-day release profile that ensures uninterrupted therapeutic exposure. This upgraded system was developed by Corium to simplify Alzheimer's care by lessening the dosing burden and supporting adherence among older adults who find daily oral medications challenging.
In August 2023, Corium Innovation Inc., a US-based biopharmaceutical company, entered into a partnership with Lotus Pharmaceuticals. The collaboration aims to develop innovations such as the innovative Alzheimer's disease treatment ADLARITY across multiple markets in Asia and establish a license agreement for ADLARITY (donepezil transdermal system), an advanced Alzheimer's dementia therapy, in ten Asian markets. Lotus Pharmaceutical is a Taiwan-based company specializing in the commercialization of both novel and generic pharmaceuticals.
Major companies operating in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy's Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group
North America was the largest region in the donepezil market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the donepezil market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the donepezil market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The donepezil market consists of sales of orally disintegrating tablets, experimental and niche products, active pharmaceutical ingredients, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Donepezil Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses donepezil market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for donepezil ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The donepezil market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Rising Long-Term Use In Alzheimer'S Disease Management
4.2.2 Increasing Preference For Oral Cognitive Enhancement Therapies
4.2.3 Growing Demand For Generic Donepezil Formulations
4.2.4 Expansion Of Treatment In Mild To Moderate Alzheimer'S Cases
4.2.5 Increased Focus On Geriatric Neurology Care
5. Donepezil Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Neurology Clinics
5.3 Geriatric Care Centers
5.4 Retail Pharmacies
5.5 Long-Term Care Facilities
6. Donepezil Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Donepezil Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Donepezil PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Donepezil Market Size, Comparisons And Growth Rate Analysis
7.3. Global Donepezil Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Donepezil Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Donepezil Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Donepezil Market Segmentation
9.1. Global Donepezil Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
5mg, 10mg, 23mg
9.2. Global Donepezil Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Transdermal
9.3. Global Donepezil Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Drugstore
10. Donepezil Market Regional And Country Analysis
10.1. Global Donepezil Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Donepezil Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Donepezil Market
11.1. Asia-Pacific Donepezil Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Donepezil Market
12.1. China Donepezil Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Donepezil Market
13.1. India Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Donepezil Market
14.1. Japan Donepezil Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Donepezil Market
15.1. Australia Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Donepezil Market
16.1. Indonesia Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Donepezil Market
17.1. South Korea Donepezil Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Donepezil Market
18.1. Taiwan Donepezil Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Donepezil Market
19.1. South East Asia Donepezil Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Donepezil Market
20.1. Western Europe Donepezil Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Donepezil Market
21.1. UK Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Donepezil Market
22.1. Germany Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Donepezil Market
23.1. France Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Donepezil Market
24.1. Italy Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Donepezil Market
25.1. Spain Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Donepezil Market
26.1. Eastern Europe Donepezil Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Donepezil Market
27.1. Russia Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Donepezil Market
28.1. North America Donepezil Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Donepezil Market
29.1. USA Donepezil Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Donepezil Market
30.1. Canada Donepezil Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Donepezil Market
31.1. South America Donepezil Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Donepezil Market
32.1. Brazil Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Donepezil Market
33.1. Middle East Donepezil Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Donepezil Market
34.1. Africa Donepezil Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Donepezil Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Donepezil Market Regulatory and Investment Landscape
36. Donepezil Market Competitive Landscape And Company Profiles
36.1. Donepezil Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Donepezil Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Donepezil Market Company Profiles
36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Teva Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Mylan NV Overview, Products and Services, Strategy and Financial Analysis
37. Donepezil Market Other Major And Innovative Companies
Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy's Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group
38. Global Donepezil Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Donepezil Market
40. Donepezil Market High Potential Countries, Segments and Strategies
40.1 Donepezil Market In 2030 - Countries Offering Most New Opportunities
40.2 Donepezil Market In 2030 - Segments Offering Most New Opportunities
